Premium
Rituximab Induced Psoriasis in an Infant
Author(s) -
Fiorillo Loretta,
Wang Charles,
Hemmati Imam
Publication year - 2014
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.12437
Subject(s) - medicine , rituximab , psoriasis , cd20 , monoclonal antibody , immunology , monoclonal , dermatology , antibody
Rituximab is a chimeric monoclonal antibody directed against the CD 20 antigen present on the surface of mature B cells. It has been widely used in the treatment of many dermatologic and rheumatologic conditions. The onset of psoriasis after rituximab therapy has not been reported in children. We report the first case of psoriasis after rituximab therapy in a 16‐month‐old boy with no other risk factors for developing psoriasis.